Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 1–1 | Cite as

Avoid cobicistat/elvitegravir-based regimens during pregnancy

Correspondence
  • 23 Downloads

Reference

  1. Cole J. Genvoya, Stribild, Tybost (elvitegravir/cobicistat) - Important Safety Information from Gilead Sciences Ltd as approved by HPRA. Internet Document : [2 pages], 26 Mar 2019. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/important-safety-information

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations